130 related articles for article (PubMed ID: 17429195)
1. Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity.
Yoon SY; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Acta Haematol; 2007; 118(1):30-7. PubMed ID: 17429195
[TBL] [Abstract][Full Text] [Related]
2. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH
Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197
[TBL] [Abstract][Full Text] [Related]
3. Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity.
Spyridopoulos I; Hoffmann J; Aicher A; Brümmendorf TH; Doerr HW; Zeiher AM; Dimmeler S
Circulation; 2009 Oct; 120(14):1364-72. PubMed ID: 19770396
[TBL] [Abstract][Full Text] [Related]
4. Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir.
Rocci A; Ricca I; Dellacasa C; Longoni P; Compagno M; Francese R; Lobetti Bodoni C; Manzini P; Caracciolo D; Boccadoro M; Ferrero D; Ladetto M; Carlo-Stella C; Tarella C
Exp Hematol; 2007 Apr; 35(4):673-81. PubMed ID: 17379077
[TBL] [Abstract][Full Text] [Related]
5. Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim.
Balducci L; Al-Halawani H; Charu V; Tam J; Shahin S; Dreiling L; Ershler WB
Oncologist; 2007 Dec; 12(12):1416-24. PubMed ID: 18165618
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-related myelosuppression as a marker of survival in epithelial ovarian cancer patients.
Rocconi RP; Matthews KS; Kemper MK; Hoskins KE; Barnes MN
Gynecol Oncol; 2008 Feb; 108(2):336-41. PubMed ID: 18006047
[TBL] [Abstract][Full Text] [Related]
7. Use of oral mucosal neutrophil counts to detect the onset and resolution of profound neutropenia following high-dose myelosuppressive chemotherapy.
Akpek G; Knight RD; Wright DG
Am J Hematol; 2003 Jan; 72(1):13-9. PubMed ID: 12508262
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic and dose escalation study of pegfilgrastim (KRN125) in lung cancer patients with chemotherapy-induced neutropenia.
Yamamoto N; Sekine I; Nakagawa K; Takada M; Fukuoka M; Tanigawara Y; Saijo N
Jpn J Clin Oncol; 2009 Jul; 39(7):425-30. PubMed ID: 19395467
[TBL] [Abstract][Full Text] [Related]
9. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
11. Neutropenic events in community practices reduced by first and subsequent cycle pegfilgrastim use.
Ozer H; Mirtsching B; Rader M; Luedke S; Noga SJ; Ding B; Dreiling L
Oncologist; 2007 Apr; 12(4):484-94. PubMed ID: 17470691
[TBL] [Abstract][Full Text] [Related]
12. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
13. Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
Gertler R; Doll D; Maak M; Feith M; Rosenberg R
Cancer; 2008 May; 112(10):2173-80. PubMed ID: 18348304
[TBL] [Abstract][Full Text] [Related]
14. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
[TBL] [Abstract][Full Text] [Related]
15. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.
Fader AN; von Gruenigen V; Gibbons H; Abushahin F; Starks D; Markman M; Belinson J; Rose P
Gynecol Oncol; 2008 Apr; 109(1):33-8. PubMed ID: 18261784
[TBL] [Abstract][Full Text] [Related]
16. Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model.
Dranitsaris G; Rayson D; Vincent M; Chang J; Gelmon K; Sandor D; Reardon G
Am J Clin Oncol; 2008 Aug; 31(4):369-74. PubMed ID: 18845996
[TBL] [Abstract][Full Text] [Related]
17. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; Béron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
[TBL] [Abstract][Full Text] [Related]
18. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease.
Bekaert S; De Meyer T; Rietzschel ER; De Buyzere ML; De Bacquer D; Langlois M; Segers P; Cooman L; Van Damme P; Cassiman P; Van Criekinge W; Verdonck P; De Backer GG; Gillebert TC; Van Oostveldt P;
Aging Cell; 2007 Oct; 6(5):639-47. PubMed ID: 17874998
[TBL] [Abstract][Full Text] [Related]
19. Telomere gap between granulocytes and lymphocytes is a determinant for hematopoetic progenitor cell impairment in patients with previous myocardial infarction.
Spyridopoulos I; Erben Y; Brummendorf TH; Haendeler J; Dietz K; Seeger F; Kissel CK; Martin H; Hoffmann J; Assmus B; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):968-74. PubMed ID: 18276909
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey.
Repetto L;
Crit Rev Oncol Hematol; 2009 Nov; 72(2):170-9. PubMed ID: 19406660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
